New Market Research Report: BioTime, Inc. (BTX) - Product Pipeline Analysis, 2013 Update
BioTime, Inc. (BioTime) is a biomedical company. It undertakes the research, development and manufacture of regenerative medicine and blood plasma volume expanders.. The company is currently developing PureStem cell lines and associated ESpan culture media, HyStem hydrogels and human embryonic stem cell lines. Its potential near term therapeutic and diagnostic product opportunities include Renevia as a cell delivery device and PanC-Dx as a novel blood-based cancer screen. The company operates in two areas of biomedical research and product development, namely,...
View full press release